Gramicidin
Polypeptide with antibacterial properties which is isolated along with tyrothricin through fermentation of Bacillus brevis.
Topically used on mucocutaneous and eye infections often in association with other antibacterial drugs such as Neomycin, Polymyxin B and others like Corticosteroids or Benzocaine.
It is highly toxic when systemically used. It has been withdrawn from the market in some countries due to lack of therapeutic effectiveness.
Given its negligible systemic absorption and high molecular weight, excretion into breastmilk is highly unlikely.
Do not apply on the breast to prevent ingestion by the infant.
Alternatives
We do not have alternatives for Gramicidin since it is relatively safe.
Very Low Risk
Compatible. Not risky for breastfeeding or infant.
Low Risk
Moderately safe. Mild risk possible. Follow up recommended. Read the Comment.
High Risk
Poorly safe. Evaluate carefully. Use a safer alternative. Read the Comment.
Very High Risk
Not recommended. Cessation of breastfeeding or alternative.
Writings
- Γραμικιδίνη (Greek)
- غراميسيدين (Arabic)
- Грамицидин (Cyrillic)
- 短杆菌肽 (Chinese)
- グラミシジン (Japanese)
- C99H140N20O17 (Molecular formula)
Drug trade names
References
- AEMPS. Oftalmowell. Ficha técnica. 2013 Full text (in our servers)
- WHO Pharmaceuticals Newsletter. 2005 Full text (link to original source) Full text (in our servers)